PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 20260 citationsOpen Access

Development of nanoparticles for blood–brain barrier crossing in the treatment of neurodegenerative diseases

View Full Paper
RFRoberta FernandesDFDébora FoguelFFFábio Formiga

Key Points

  • The aim is to develop novel nanoparticles that can effectively cross the blood-brain barrier to deliver therapies for neurodegenerative diseases.
  • Developed and tested nanoparticles for blood-brain barrier transport.
  • Assessed the effectiveness of nanoparticles in targeting neurodegenerative conditions.
  • Conducted preclinical evaluations to analyze efficacy and safety of the treatment.
  • Demonstrated successful crossing of the blood-brain barrier by the novel nanoparticles.
  • Showed significant enhancement in therapy delivery for neurodegenerative conditions during trials.
  • Achieved improved neuroprotective effects in preclinical models compared to traditional methods.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fernandes et al. (2026) studied this question.

synapsesocial.com/papers/6a192c0ffab5b468c44150d9https://doi.org/10.35259/isi.2026_76331
Ask AI
Helpful
Bookmark
Share
View Full Paper